Translink Advised Peak Proteins On The 100% Sale To Sygnature Discovery
Translink Corporate Finance in the UK advised a rapidly growing contract research organisation, Peak Proteins, on the 100% sale to a leading independent integrated drug discovery and non-clinical services company, Sygnature Discovery.